Patient characteristics, burden and pharmacotherapy of treatment-resistant schizophrenia: results from a survey of 204 US psychiatrists

Por Correll, Christoph U., Brevig, Thomas, Brain, Cecilia
Publicado no BMC Psychiatry (2019)

Exploration of Treatment-Resistant Schizophrenia Subtypes Based on a Survey of 204 US Psychiatrists

Por Correll, Christoph U, Brevig, Thomas, Brain, Cecilia
Publicado no Neuropsychiatr Dis Treat (2019)

Experiences, attitudes, and perceptions of caregivers of individuals with treatment-resistant schizophrenia: a qualitative study

Por Brain, Cecilia, Kymes, Steven, DiBenedetti, Dana B., Brevig, Thomas, Velligan, Dawn I.
Publicado no BMC Psychiatry (2018)

Hydrodynamic guiding for addressing subsets of immobilized cells and molecules in microfluidic systems

Por Brevig, Thomas, Krühne, Ulrich, Kahn, Rachel A, Ahl, Thomas, Beyer, Michael, Pedersen, Lars H
Publicado em 2003

Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials

Por Smith, Timothy R., Spierings, Egilius L. H., Cady, Roger, Hirman, Joe, Schaeffler, Barbara, Shen, Vivienne, Sperling, Bjørn, Brevig, Thomas, Josiassen, Mette Krog, Brunner, Elizabeth, Honeywell, Loan, Mehta, Lahar
Publicado no J Headache Pain (2021)